oxidopamine has been researched along with Colonic Inertia in 2 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Colonic Inertia: Symptom characterized by the passage of stool once a week or less.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Constipation is extremely common in patients with Parkinson's disease (PD) and has been described in PD animal models." | 1.42 | Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: relevance to gastrointestinal dysfunctions in Parkinson's disease. ( Ambrosi, G; Balestra, B; Blandini, F; Bonizzi, A; Cerri, S; Ferrigno, A; Ghezzi, C; Levandis, G; Pastoris, O; Rizzo, V; Siani, F; Vairetti, M; Vicini, R, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karasawa, H | 1 |
| Pietra, C | 1 |
| Giuliano, C | 1 |
| Garcia-Rubio, S | 1 |
| Xu, X | 1 |
| Yakabi, S | 1 |
| Taché, Y | 1 |
| Wang, L | 1 |
| Levandis, G | 1 |
| Balestra, B | 1 |
| Siani, F | 1 |
| Rizzo, V | 1 |
| Ghezzi, C | 1 |
| Ambrosi, G | 1 |
| Cerri, S | 1 |
| Bonizzi, A | 1 |
| Vicini, R | 1 |
| Vairetti, M | 1 |
| Ferrigno, A | 1 |
| Pastoris, O | 1 |
| Blandini, F | 1 |
2 other studies available for oxidopamine and Colonic Inertia
| Article | Year |
|---|---|
New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Brain; Constipation; Gastrointestinal Transit; Ghrelin; Immunohistoch | 2014 |
Response of colonic motility to dopaminergic stimulation is subverted in rats with nigrostriatal lesion: relevance to gastrointestinal dysfunctions in Parkinson's disease.
Topics: Animals; Chromatography, High Pressure Liquid; Colon; Constipation; Disease Models, Animal; Dopamine | 2015 |